How to use Technologies searched

A search for a company looking for a cancer, preclinical stage, synthetic opportunity would use the selection "Biomedicine, Diagnostics" in 'Sector', 'Cancerous, neoplasmatic' in 'Disease Category', 'Drugs, Small Molecule' in 'Technology' and 'Preclinical' in 'Development Stage'.

Selection of 'Enabling Technology, Platform technology' in 'Sector' will identify all kinds of searches for technologies that can be used in more areas of life sciences than pharmaceuticals only.

Each search profile gives the name or a short description of the company behind the search, and a link allowing to contact your potential licensee.

Registered users can create non-public notifications profiles which will inform them about new Technologies Searched entries fitting their expertise as specified. In addition these profiles allow them to filter the available information more comfortably.


Areas of Interest at Desitin Pharmaceuticals

Organization name

Desitin Pharmaceuticals business development


Desitin Pharmaceuticals is an independent medium-sized German enterprise, active in national and international markets.

At their Hamburg site, sophisticated products for the therapy of neurological and psychiatric disorders are produced. They offer a wide variety of established and innovative products, particularly for their focus indications - epilepsy and Parkinson's disease. Their expertise in the area of central nervous system diseases is well-known among specialists in the field.

The main focus of their efforts is in the area of research and development: Their research team is working continuously and intensively on the optimization of pharmaceutical therapy and devotes a large share of its work to specialized innovative development projects.  

In collaboration with other future-oriented enterprises, for example, in the area of biotechnology, they will continue to develop and produce successful products for the treatment of central nervous system diseases.

They are seeking

  • innovative CNS products / technologies in late stage of clinical development or already marketed

for co-marketing or co- promotion in Germany and/or their further European markets.

  • further products for CNS disorders including epilepsy, parkinson disease and psychiatric indications

for all countries in which they are active.

  • Innovative CNS biotechnology products / technologies in early stage of clinical development

for in-licensing in Germany and further European markets

To view the contact information, attachments and url of this profile you have to login into your account or register a new account: Login Register

Your feedback

Please click here to log in to view the complete profile.


latest entries